{
  "meta": {
    "title": "46_Investigation_Of_Respiratory_System",
    "url": "https://brainandscalpel.vercel.app/46-investigation-of-respiratory-system-c92ba99f.html",
    "scrapedAt": "2025-11-30T06:57:21.785Z"
  },
  "questions": [
    {
      "id": 95790,
      "choices": [
        {
          "id": 207491,
          "text": "Reassure"
        },
        {
          "id": 207492,
          "text": "Chest CT"
        },
        {
          "id": 207493,
          "text": "Bronchoscopy"
        },
        {
          "id": 207494,
          "text": "Angiography"
        }
      ],
      "text": "A 60 Y M smoker patient presented with haemoptysis and persistent cough. The CXR is normal. The next best investigation is",
      "unique_key": "Q9032084",
      "question_audio": null,
      "question_video": null,
      "map_id": 34656151,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Chest CT. In a 60-year-old male smoker presenting with hemoptysis and a persistent cough, even if the chest X-ray (CXR) appears normal, the next best step is to perform a Chest CT (computed tomography). This is because a normal chest X-ray does not rule out significant lung pathology, especially in smokers who are at higher risk for lung cancer, chronic obstructive pulmonary disease (COPD), or other serious pulmonary conditions. A Chest CT provides more detailed imaging and can help identify the causes of hemoptysis that may not be visible on a standard chest X-ray, such as small tumors, pulmonary nodules, vascular malformations, or other pulmonary diseases. Therefore, a Chest CT is the most appropriate next step for further evaluation. Incorrect Options: A. Reassure (incorrect): Given the patient's age and smoking history, reassurance alone is not appropriate. Hemoptysis and a persistent cough in this population raise significant concerns for serious conditions like lung cancer, tuberculosis, or bronchitis, among others. It is crucial to conduct further investigations to rule out potentially life-threatening causes rather than simply reassuring the patient. This option is incorrect as it would delay appropriate diagnosis and treatment. C. Bronchoscopy (incorrect): Although bronchoscopy is useful in evaluating the airway for bleeding sources and pathology such as tumors or foreign bodies, it is not the initial investigation when CXR is normal. A Chest CT provides a comprehensive view of the lungs and is more likely to identify abnormalities that may then guide the decision for bronchoscopy. Typically, bronchoscopy is performed if imaging (like a CT) reveals a potential airway problem. This option is incorrect as a first-line test in this scenario. D. Angiography (incorrect): Angiography is typically used to identify vascular abnormalities like pulmonary arteriovenous malformations or bronchial artery hemorrhages that may cause hemoptysis. However, it is not the first-line diagnostic test for a patient with normal CXR. Chest CT is the preferred initial imaging modality to evaluate the lungs for a variety of potential causes of hemoptysis, including malignancies, infections, or structural abnormalities. Therefore, angiography is incorrect as the first investigation.",
      "correct_choice_id": 207492,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95791,
      "choices": [
        {
          "id": 207495,
          "text": "Pulmonary fibrosis"
        },
        {
          "id": 207496,
          "text": "ILD"
        },
        {
          "id": 207497,
          "text": "Alveolar hemorrhage"
        },
        {
          "id": 207498,
          "text": "Severe emphysema"
        }
      ],
      "text": "DLCO is decreased in all except",
      "unique_key": "Q3234430",
      "question_audio": null,
      "question_video": null,
      "map_id": 34111598,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Alveolar hemorrhage. Diffusing capacity for carbon monoxide (DLCO) is a test that measures how well gases like oxygen and carbon dioxide can diffuse across the alveolar-capillary membrane. DLCO is decreased in conditions where the gas exchange area in the lungs is compromised, such as pulmonary fibrosis, interstitial lung disease (ILD), or emphysema. However, in alveolar hemorrhage, where blood is present in the alveolar spaces, DLCO can actually be increased. This is because the blood within the alveoli enhances the diffusion of carbon monoxide, artificially raising the DLCO. Therefore, alveolar hemorrhage does not lead to a decrease in DLCO, making it the correct answer to this question. Incorrect Options: A. Pulmonary fibrosis (incorrect): In pulmonary fibrosis, the lung tissue becomes scarred and stiff, which leads to a reduction in the surface area for gas exchange. This results in a decreased DLCO because the diffusion of gases like oxygen is impaired. The fibrotic changes reduce the ability of gases to cross the alveolar-capillary membrane effectively. Thus, pulmonary fibrosis is a condition where DLCO is decreased, making this option incorrect. B. Interstitial lung disease (ILD) (incorrect): Interstitial lung disease (ILD) includes a group of disorders that involve inflammation and scarring of the lung's interstitial tissue, impairing gas exchange. This damage decreases the DLCO, as the scarring or inflammation reduces the functional alveolar surface area. Therefore, in ILD, DLCO is typically decreased, making this option incorrect. D. Severe emphysema (incorrect): In severe emphysema, the lung tissue is destroyed, particularly the alveolar walls, leading to a decrease in the surface area available for gas exchange. This impairment reduces DLCO in emphysema, as the structural damage limits the ability of gases to diffuse across the alveolar-capillary membrane. Thus, severe emphysema is associated with a decreased DLCO, making this option incorrect.",
      "correct_choice_id": 207497,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95792,
      "choices": [
        {
          "id": 207499,
          "text": "0.3%"
        },
        {
          "id": 207500,
          "text": "0.5%"
        },
        {
          "id": 207501,
          "text": "0.75%"
        },
        {
          "id": 207502,
          "text": "1.0%"
        }
      ],
      "text": "What concentration of carbon monoxide is inhaled to assess DLco",
      "unique_key": "Q4395069",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197921,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 0.3%. DLCO (Diffusing capacity of the lungs for carbon monoxide) is a test that measures how well gases like oxygen diffuse from the lungs into the bloodstream. During this test, a small concentration of carbon monoxide (CO) is inhaled to assess how effectively it is transferred across the alveolar-capillary membrane. The typical concentration of CO used in the DLCO test is 0.3% (or 3,000 parts per million). This low concentration is chosen because it allows for accurate measurement of the diffusing capacity without causing harm to the patient. Incorrect Options: B. 0.5% (incorrect): While 0.5% is a higher concentration than what is typically used in the DLCO test, it is still a concentration that might be used in some specific settings. However, the standard concentration for assessing DLCO is 0.3%, making this answer incorrect. C. 0.75% (incorrect): A concentration of 0.75% is even higher than 0.5% and is not commonly used in DLCO tests. The concentration for carbon monoxide is usually 0.3% to ensure both safety and accuracy, so 0.75% is not the correct concentration for this test. D. 1.0% (incorrect): Similarly, 1.0% would be an excessive concentration for the DLCO test. It could result in inaccurate measurements and would not be used in a standard clinical setting. The optimal concentration remains 0.3% for accurate and safe testing.",
      "correct_choice_id": 207499,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95793,
      "choices": [
        {
          "id": 207503,
          "text": "↑ TLC"
        },
        {
          "id": 207504,
          "text": "↑ RV"
        },
        {
          "id": 207505,
          "text": "↓ Vital capacity"
        },
        {
          "id": 207506,
          "text": "↑ FEV1/FVC ratio"
        }
      ],
      "text": "All of the following are expected PFT changes in a patient with interstitial lung disease except",
      "unique_key": "Q5707852",
      "question_audio": null,
      "question_video": null,
      "map_id": 34622047,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) In interstitial lung disease (ILD), the lungs become stiff due to fibrosis, leading to restrictive lung disease, where the ability to expand the lungs is reduced. • TLC (Total Lung Capacity) is decreased in ILD because the stiffening of lung tissue reduces lung expansion during inspiration. • RV (Residual Volume) can increase in some cases due to air trapping, but is usually normal or slightly increased. • Vital Capacity (VC) is decreased due to reduced lung compliance and restricted expansion. The FEV1/FVC ratio tends to increase in ILD because both FEV1 and FVC decrease, but FVC decreases more than FEV1, leading to an increased ratio. Thus, A. ? TLC is the only finding that is not expected in ILD, making it the correct answer to the \"except\" question.",
      "correct_choice_id": 207503,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95794,
      "choices": [
        {
          "id": 207507,
          "text": "Decrease TLC"
        },
        {
          "id": 207508,
          "text": "Normal RV"
        },
        {
          "id": 207509,
          "text": "Increase RV/TLC ratio"
        },
        {
          "id": 207510,
          "text": "None of the above"
        }
      ],
      "text": "All of the following are expected PFT changes in a patient with kyphoscoliosis except",
      "unique_key": "Q4455687",
      "question_audio": null,
      "question_video": null,
      "map_id": 34536650,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) A. ↓ TLC (Total Lung Capacity): This statement is True. In restrictive lung diseases like kyphoscoliosis, the ability of the lungs to expand is reduced due to the deformed chest wall. This leads to a decrease in all lung volumes, including Total Lung Capacity (TLC). B. Normal RV (Residual Volume): This statement is generally False. In restrictive lung diseases, while all lung volumes are reduced, the Residual Volume (RV) tends to be proportionally less reduced or even appear relatively normal compared to the significant reduction in TLC. This leads to a relative increase in the RV/TLC ratio. However, the absolute RV is usually reduced. Stating it's \"Normal\" is often an oversimplification, as it's typically reduced but to a lesser extent than other volumes. C. ↑ RV/TLC ratio: This statement is True. Since both RV and TLC are reduced, but RV is proportionally less reduced than TLC (or can even be near normal while TLC is significantly down), the ratio of Residual Volume to Total Lung Capacity often increases in restrictive lung diseases. D. None of the above: This option would be true if all other statements were correct. RV is normal but TLC decreases , RV/TLC ratio INCREASES . RV/TLC RATIO helps us to differentiate between intrinsic and Respiratory lung diseases ..",
      "correct_choice_id": 207508,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95795,
      "choices": [
        {
          "id": 207511,
          "text": "increased FeV1"
        },
        {
          "id": 207512,
          "text": "increased total lung capacity"
        },
        {
          "id": 207513,
          "text": "reduced functional residual capacity"
        },
        {
          "id": 207514,
          "text": "increased vital capacity"
        }
      ],
      "text": "A 35-year-old, non smoker male seeks medical attention for breathlessness on exertion. One sibling died of respiratory failure at 40 years of age. Physical examination reveals him to be tachypneic as he exhales through pursed lips. Chest x-ray show flattened diaphragms with peripheral attenuation of bronchovascular markings that is most noticeable at the lung bases.Expected resultsof the pulmonary function testing of the man described above would include",
      "unique_key": "Q8965576",
      "question_audio": null,
      "question_video": null,
      "map_id": 34674820,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Increased total lung capacity (TLC) The patient described is most likely suffering from chronic obstructive pulmonary disease (COPD), given the symptoms (breathlessness, pursed lip breathing), signs (tachypnea, flattened diaphragms), and imaging findings (flattened diaphragms with peripheral attenuation of bronchovascular markings). These signs and symptoms are commonly seen in emphysema, a type of COPD. In emphysema, there is air trapping due to obstructed airflow. This air trapping leads to an increase in total lung capacity (TLC) as the lungs become hyperinflated, trying to compensate for the obstructed outflow of air. Therefore, increased TLC is the expected result on pulmonary function testing. Explanation for the incorrect options: A. Increased FEV1 (incorrect): In obstructive lung diseases like emphysema, the forced expiratory volume in 1 second (FEV1) is typically reduced. This reduction occurs because the airflow is obstructed, making it harder to expel air from the lungs, especially during forced expiration. The patient will likely exhibit decreased FEV1 rather than increased FEV1 on pulmonary function testing. C. Reduced functional residual capacity (FRC) (incorrect): In emphysema, functional residual capacity (FRC) is generally increased rather than decreased. FRC is the volume of air left in the lungs after a normal exhalation. In obstructive lung diseases like emphysema, the lungs become hyperinflated, leading to an increase in the amount of air that remains in the lungs after expiration. Therefore, reduced FRC would not be expected in this patient. D. Increased vital capacity (VC) (incorrect): In emphysema, the vital capacity (VC) may be either normal or slightly reduced, but it is not expected to be increased. This is because the lungs are hyperinflated due to air trapping, but the ability to expel air (which defines VC) is diminished due to obstructed airflow. Therefore, increased VC would not be expected in this patient.",
      "correct_choice_id": 207512,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95796,
      "choices": [
        {
          "id": 207515,
          "text": "body plethysmography"
        },
        {
          "id": 207516,
          "text": "diffusing capacity of carbon monoxide"
        },
        {
          "id": 207517,
          "text": "spirometry"
        },
        {
          "id": 207518,
          "text": "helium dilution"
        }
      ],
      "text": "In a patient with severe bullous emphysema, themost appropriate method for measuring lung volumes is",
      "unique_key": "Q1813164",
      "question_audio": null,
      "question_video": null,
      "map_id": 34277739,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Body plethysmography In patients with severe bullous emphysema, the most appropriate method for measuring lung volumes is body plethysmography. This is because body plethysmography directly measures the total lung capacity (TLC) and residual volume (RV), including the volumes that may be trapped in areas of the lungs that are poorly ventilated, such as in the bullous spaces of emphysema. These areas can be missed or inaccurately measured using other methods, especially with the distortion caused by emphysema. Body plethysmography works by measuring changes in pressure within a sealed chamber as the patient breathes, which allows it to account for air trapped in these poorly ventilated regions. Explanation for the incorrect options: B. Diffusing capacity of carbon monoxide (incorrect): The diffusing capacity of carbon monoxide (DLCO) measures the ability of the lungs to transfer gas from the alveoli to the bloodstream. While it is a useful test for assessing lung function, particularly in restrictive or interstitial lung diseases, it does not directly measure lung volumes, which is the focus of this question. Therefore, DLCO would not be the most appropriate method for measuring lung volumes in a patient with bullous emphysema. C. Spirometry (incorrect): Spirometry measures forced expiratory volumes such as FEV1 and FVC but does not provide direct measurements of lung volumes like total lung capacity (TLC) or residual volume (RV). In bullous emphysema, air trapping may cause spirometry to underestimate the degree of hyperinflation, as it cannot fully account for the air in the non-ventilated spaces of the lung. Therefore, spirometry alone is not sufficient to measure lung volumes in this case. D. Helium dilution (incorrect): The helium dilution technique is commonly used to measure lung volumes, particularly the functional residual capacity (FRC) and total lung capacity (TLC). However, it is less accurate in patients with severe emphysema, particularly in those with bullous emphysema, because it may underestimate the total lung volume due to areas of the lung that are poorly ventilated or non-functional. The helium dilution method assumes uniform distribution of helium in the lung, which is not the case in emphysema, where ventilation is uneven.",
      "correct_choice_id": 207515,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95797,
      "choices": [
        {
          "id": 207519,
          "text": "Increased FeV1"
        },
        {
          "id": 207520,
          "text": "Increased total lung capacity"
        },
        {
          "id": 207521,
          "text": "Reduced functional residual capacity"
        },
        {
          "id": 207522,
          "text": "Increased vital capacity"
        }
      ],
      "text": "A 65-year-old man seeks medical attention for breathlessness on exertionandchronic cough that have worsened progressively over the past12 months. On auscultation bilateral fine crepitations are heard. On HRCT, bilateral reticular opacities and clustered basal honeycombing arefound. Expected results of the pulmonary function testing of the man described above would include",
      "unique_key": "Q3510043",
      "question_audio": null,
      "question_video": null,
      "map_id": 34605321,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Reduced functional residual capacity The most likely diagnosis for the 65-year-old man is interstitial lung disease (ILD), specifically a type of pulmonary fibrosis (such as idiopathic pulmonary fibrosis, IPF). In ILD, the lungs become stiff and scarred, leading to restrictive lung disease. One of the hallmark features of restrictive lung diseases is reduced functional residual capacity (FRC). FRC is the volume of air remaining in the lungs after normal exhalation, and in restrictive lung diseases, the lungs are less able to expand, leading to a decrease in this volume. Explanation for the incorrect responses: A. Increased FEV1 (incorrect): In restrictive lung diseases, including pulmonary fibrosis, the forced expiratory volume in one second (FEV1) is typically either normal or reduced. However, FEV1 is not usually increased in these conditions. The primary issue in restrictive lung disease is the reduced ability of the lungs to expand, rather than airflow obstruction, which is more characteristic of obstructive diseases (like COPD or asthma). B. Increased total lung capacity (incorrect): In restrictive lung disease, total lung capacity (TLC) is typically decreased, not increased. The stiffness and scarring of the lung tissue reduce the lung's ability to expand, leading to reduced lung volumes, including TLC. Increased TLC would be seen in obstructive diseases (like emphysema) where air trapping occurs. D. Increased vital capacity (incorrect): In pulmonary fibrosis, the vital capacity (VC), which is the maximum amount of air that can be exhaled after taking a deep breath, is typically decreased due to the scarring and stiffness of the lungs. Increased vital capacity would be inconsistent with the restrictive pattern seen in diseases like pulmonary fibrosis.",
      "correct_choice_id": 207521,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95798,
      "choices": [
        {
          "id": 207523,
          "text": "Increased total lung capacity (TLC), decreased vital capacity (VC), decreased FEV1/FVC ratio"
        },
        {
          "id": 207524,
          "text": "Decreased TLC, decreased VC, decreased residual volume (RV), increased FEV1/FVC ratio,"
        },
        {
          "id": 207525,
          "text": "Decreased TLC, increased RV, normal FEV1/FVC ratio, decreased DLCO"
        },
        {
          "id": 207526,
          "text": "Normal TLC, normal RV, normal FEV1/FVC ratio, decreased DLCO"
        }
      ],
      "text": "Match the pulmonary function test results to Idiopathic Pulmonary hypertension which it is most likely to be found.",
      "unique_key": "Q3361116",
      "question_audio": null,
      "question_video": null,
      "map_id": 34748239,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Normal TLC, normal RV, normal FEV1/FVC ratio, decreased DLCO Idiopathic pulmonary hypertension (IPAH) is a condition characterized by increased pressure in the pulmonary arteries without an identifiable cause. The hallmark of IPAH is pulmonary vasoconstriction and vascular remodeling, which leads to increased pulmonary artery pressures and right heart strain. Pulmonary function tests (PFTs) in IPAH often show normal lung volumes, with normal total lung capacity (TLC) and residual volume (RV), and a normal FEV1/FVC ratio. However, diffusing capacity of the lungs for carbon monoxide (DLCO) is typically decreased due to impaired gas exchange at the level of the alveoli due to vascular changes. Explanation for the incorrect responses: A. Increased total lung capacity (TLC), decreased vital capacity (VC), decreased FEV1/FVC ratio (incorrect): This pattern is not typical for IPAH. An increased TLC and decreased VC typically suggest obstructive or restrictive lung disease, but this does not align with IPAH. IPAH generally does not cause changes in lung volumes like increased TLC or decreased VC. The decreased FEV1/FVC ratio is also more indicative of obstructive lung diseases, which is not characteristic of IPAH. B. Decreased TLC, decreased VC, decreased residual volume (RV), increased FEV1/FVC ratio (incorrect): A decreased TLC and decreased RV with an increased FEV1/FVC ratio would suggest a restrictive pattern, where there is a reduction in lung volumes due to parenchymal lung diseases like interstitial lung disease (ILD). While IPAH can result in restrictive lung disease patterns, it does not typically cause such drastic reductions in TLC and RV or an increased FEV1/FVC ratio. C. Decreased TLC, increased RV, normal FEV1/FVC ratio, decreased DLCO (incorrect): While decreased DLCO and a normal FEV1/FVC ratio might be seen in IPAH, the presence of decreased TLC and increased RV would suggest a pattern seen in diseases like emphysema or other conditions with air trapping. IPAH generally does not result in significant reductions in TLC or increases in RV, as it typically spares lung volumes initially.",
      "correct_choice_id": 207526,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95799,
      "choices": [
        {
          "id": 207527,
          "text": "Cardiac or respiratory arrest"
        },
        {
          "id": 207528,
          "text": "Severe encephalopathy"
        },
        {
          "id": 207529,
          "text": "Severe gastrointestinal bleed"
        },
        {
          "id": 207530,
          "text": "COPD exacerbation"
        }
      ],
      "text": "Following is an contraindication for NIV except",
      "unique_key": "Q7685817",
      "question_audio": null,
      "question_video": null,
      "map_id": 34018340,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) COPD exacerbation Non-invasive ventilation (NIV) is commonly used in patients with COPD exacerbations to improve oxygenation and reduce carbon dioxide retention, making it one of the key indications for its use. NIV helps reduce the work of breathing, supports ventilation, and decreases the need for invasive intubation in COPD patients experiencing exacerbations. Therefore, COPD exacerbation is not a contraindication for NIV and is instead a primary condition where NIV can provide significant benefit. Explanation for the incorrect responses: A. Cardiac or respiratory arrest (incorrect): Cardiac or respiratory arrest is a contraindication for NIV because in these situations, the patient requires immediate resuscitation and invasive ventilation. NIV cannot provide the necessary respiratory support during a cardiac or respiratory arrest. In such cases, invasive mechanical ventilation is required for proper management. B. Severe encephalopathy (incorrect): Severe encephalopathy is a contraindication for NIV because it impairs the patient's ability to maintain an adequate airway or cooperate with the NIV treatment. Encephalopathy can cause altered mental status, which may make it difficult for the patient to tolerate the mask or other interfaces required for NIV, and may lead to an increased risk of aspiration or airway obstruction. C. Severe gastrointestinal bleed (incorrect): Severe gastrointestinal bleed is also a contraindication for NIV because the use of NIV increases the risk of gastric insufflation (air entering the stomach), which can increase the risk of aspiration. In patients with active gastrointestinal bleeding, this is particularly dangerous, as it can worsen the bleeding or lead to aspiration of blood into the lungs.",
      "correct_choice_id": 207530,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95800,
      "choices": [
        {
          "id": 207531,
          "text": "Decreases work of breathing"
        },
        {
          "id": 207532,
          "text": "Can reduce the need for intubation and hospital morbidity."
        },
        {
          "id": 207533,
          "text": "Failure is associated with a higher mortality in respiratory failure."
        },
        {
          "id": 207534,
          "text": "NIV hashad limited success in patients with acute hypercapnic respiratory failure."
        }
      ],
      "text": "Regarding Non-invasive ventilation (NIV) all are true except :",
      "unique_key": "Q1919968",
      "question_audio": null,
      "question_video": null,
      "map_id": 34050294,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) NIV has had limited success in patients with acute hypercapnic respiratory failure. This statement is incorrect. Non-invasive ventilation (NIV) has been shown to be effective in managing acute hypercapnic respiratory failure, particularly in conditions like COPD exacerbations and acute asthma. NIV helps reduce the work of breathing, improves ventilation, and decreases the need for intubation in these patients. As such, NIV is not limited in its success but is, in fact, an important tool for managing hypercapnic respiratory failure, provided it is used appropriately. Explanation for the incorrect responses: A. Decreases work of breathing (correct): One of the primary benefits of NIV is that it reduces the work of breathing. NIV delivers positive pressure to help the patient breathe more easily, thus decreasing the effort required for ventilation, improving oxygenation, and reducing the burden on respiratory muscles. This is particularly useful in patients with obstructive or restrictive lung diseases. B. Can reduce the need for intubation and hospital morbidity (correct): NIV has been shown to reduce the need for intubation and hospital morbidity in patients with acute respiratory failure. By improving gas exchange and reducing the effort of breathing, NIV can prevent the progression of respiratory distress to the point where intubation would be necessary. This leads to shorter hospital stays, reduced complications, and better overall outcomes. C. Failure is associated with a higher mortality in respiratory failure (correct): If NIV fails to improve a patient's respiratory status, it is associated with higher mortality rates. Failure of NIV indicates that the patient may require intubation and mechanical ventilation. Delayed or ineffective NIV can result in deterioration of the patient's condition, which may contribute to increased complications and mortality, especially in patients with severe respiratory failure.",
      "correct_choice_id": 207534,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95801,
      "choices": [
        {
          "id": 207535,
          "text": "Measurement of lung water"
        },
        {
          "id": 207536,
          "text": "Measurement of arterial PCO2"
        },
        {
          "id": 207537,
          "text": "Measurement of pulmonary artery wedge pressure"
        },
        {
          "id": 207538,
          "text": "Measure of lung compliance"
        }
      ],
      "text": "A 51-year-old man develops pancreatitis associated with the passage of a gallstone. Two days later he becomes anxious, tachypneic, and short of breath. An emergency chest x-ray demonstrates diffuse, bilateral interstitial and alveolar infiltrates. In this case, adult respiratory distress syndrome can be distinguished from cardiogenic pulmonary edema by which of the following?",
      "unique_key": "Q1807822",
      "question_audio": null,
      "question_video": null,
      "map_id": 34199656,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Measurement of pulmonary artery wedge pressure Explanation for the correct response: In Adult Respiratory Distress Syndrome (ARDS), the cause of pulmonary edema is primarily non-cardiogenic, resulting from damage to the alveolar-capillary barrier leading to increased permeability and fluid accumulation in the lungs. On the other hand, cardiogenic pulmonary edema is due to increased pulmonary venous pressure, usually secondary to left-sided heart failure or volume overload. The most reliable way to distinguish between ARDS and cardiogenic pulmonary edema is by measuring the pulmonary artery wedge pressure (PAWP), which reflects left atrial pressure. In cardiogenic pulmonary edema, the PAWP is typically elevated due to increased pressure from the heart's left side, while in ARDS, the PAWP is usually normal (as the edema is not due to heart failure but rather to pulmonary injury). Explanation for the incorrect responses: A. Measurement of lung water (incorrect): While measuring lung water can be used to assess the degree of edema in the lungs, it is not a routine or practical diagnostic test for distinguishing between ARDS and cardiogenic pulmonary edema. Lung water measurement typically requires invasive techniques like gravimetric analysis or a catheter that isn't commonly available in clinical settings. B. Measurement of arterial PCO2 (incorrect): The arterial PCO2 (partial pressure of carbon dioxide) can reflect ventilation-perfusion mismatching and the patient’s ability to clear CO2 but cannot definitively distinguish between ARDS and cardiogenic pulmonary edema. Both conditions can cause tachypnea and hypoxemia, and thus a measurement of PCO2 alone will not provide clear differentiation. D. Measurement of lung compliance (incorrect): In ARDS, there is often reduced lung compliance due to alveolar flooding, atelectasis, and fibrosis, whereas in cardiogenic pulmonary edema, compliance may remain relatively normal or decreased to a lesser extent. However, measuring lung compliance alone is not specific enough to differentiate between ARDS and cardiogenic pulmonary edema. The change in compliance is more of a general marker of the extent of pulmonary involvement rather than a definitive diagnostic tool.",
      "correct_choice_id": 207537,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95802,
      "choices": [
        {
          "id": 207539,
          "text": "Increase in FEV1/FVC"
        },
        {
          "id": 207540,
          "text": "> 200 ml increase in FeV1 after methacholine"
        },
        {
          "id": 207541,
          "text": "Diurnal variation PEFR > 20%"
        },
        {
          "id": 207542,
          "text": "Reduction in FeV1 > 20% after bronchodilators"
        }
      ],
      "text": "In a patient with clinical signs of asthma which of the following tests will suggest diagnosis?",
      "unique_key": "Q9684133",
      "question_audio": null,
      "question_video": null,
      "map_id": 34856053,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Diurnal variation PEFR > 20%. In a patient with clinical signs of asthma, one of the most suggestive tests is the diurnal variation in Peak Expiratory Flow Rate (PEFR). A diurnal variation greater than 20% indicates variability in airflow which is typical of asthma, as asthma is characterized by fluctuating airway obstruction that worsens at night or early in the morning. This variability in airflow can be tracked over a period of time with self-monitoring PEFR, helping to diagnose asthma based on these daily fluctuations. Why Other Options Are Incorrect: (A) Increase in FEV1/FVC: This is incorrect because an increase in the FEV1/FVC ratio would actually suggest restrictive lung disease or a normal response in healthy individuals, not asthma. In asthma, FEV1 is often reduced due to airflow obstruction, and the FEV1/FVC ratio may be reduced, especially during exacerbations, making this test not suggestive of asthma. (B) > 200 ml increase in FEV1 after methacholine: This is incorrect because while an increase in FEV1 after methacholine suggests bronchodilator responsiveness, methacholine testing is a challenge test used to assess airway hyperresponsiveness. However, an increase in FEV1 of > 200 mL after methacholine is not the criterion for asthma diagnosis. Methacholine is used to provoke bronchoconstriction, and its positive result indicates hyperreactive airways, but it does not directly confirm asthma in every case. (D) Reduction in FEV1 > 20% after bronchodilators: This is incorrect because a reduction in FEV1 after bronchodilators is not expected in asthma. Typically, in asthma, bronchodilators lead to an increase in FEV1 due to bronchodilation, which relieves the airway obstruction. A reduction in FEV1 after bronchodilators suggests other causes of lung disease, such as chronic obstructive pulmonary disease (COPD) or other restrictive diseases, rather than asthma.",
      "correct_choice_id": 207541,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95803,
      "choices": [
        {
          "id": 207543,
          "text": "Milky appearance with foamy macrophages"
        },
        {
          "id": 207544,
          "text": "Ferruginous bodies"
        },
        {
          "id": 207545,
          "text": "Hemosiderin laden macrophages"
        },
        {
          "id": 207546,
          "text": "Lymphocytosis with an elevated CD4:CD8 ratio"
        }
      ],
      "text": "What would be the expected finding on bronchoalveolar lavage in a patient with diffuse alveolar hemorrhage?",
      "unique_key": "Q2146829",
      "question_audio": null,
      "question_video": null,
      "map_id": 34666861,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hemosiderin-laden macrophages. In patients with diffuse alveolar hemorrhage (DAH), bronchoalveolar lavage (BAL) typically reveals hemosiderin-laden macrophages. These macrophages contain iron pigment (hemosiderin) which accumulates as a result of hemorrhage into the alveolar spaces. When bleeding occurs in the lungs, the red blood cells break down, and macrophages ingest the hemoglobin. The iron from hemoglobin is stored as hemosiderin within the macrophages, which is a hallmark finding in DAH. This finding is often used as an indicator of chronic hemorrhage and can be seen several hours to days after the hemorrhage has occurred. Why the other options are incorrect: A. Milky appearance with foamy macrophages: This finding is typically seen in conditions like pulmonary alveolar proteinosis (PAP), not in diffuse alveolar hemorrhage. In PAP, the alveolar spaces are filled with lipid-rich surfactant, giving the BAL fluid a milky appearance and foamy macrophages. This is different from the hemosiderin-laden macrophages found in DAH, which reflects bleeding, not surfactant accumulation. B. Ferruginous bodies: Ferruginous bodies are associated with the inhalation of asbestos fibers, often seen in asbestosis or mesothelioma. These bodies are asbestos fibers coated with iron and protein. They are not found in diffuse alveolar hemorrhage, where the primary finding would be hemosiderin-laden macrophages due to bleeding. D. Lymphocytosis with an elevated CD4:CD8 ratio: This finding is characteristic of hypersensitivity pneumonitis (HP) or other interstitial lung diseases with an inflammatory or immune-mediated origin, but not diffuse alveolar hemorrhage. In DAH, the predominant finding on BAL is hemosiderin-laden macrophages rather than lymphocytosis or elevated CD4:CD8 ratios, which reflect a T-cell-mediated inflammatory response rather than hemorrhage.",
      "correct_choice_id": 207545,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95804,
      "choices": [
        {
          "id": 207547,
          "text": "SpO2 of the patient should be monitored since the drug causes eosinophillic lung disease"
        },
        {
          "id": 207548,
          "text": "BP monitoring should be done and drug should be stopped if BP < 100/70mmHg"
        },
        {
          "id": 207549,
          "text": "ECG monitoring should be done to look for QTc prolongation and drug is avoided or should be stopped if QTc > 500ms"
        },
        {
          "id": 207550,
          "text": "ECG monitoring should be done and HCQ should be voided if QTc > 320ms"
        }
      ],
      "text": "While giving hydroxychloroquin, what all should be monitored ?",
      "unique_key": "Q8384915",
      "question_audio": null,
      "question_video": null,
      "map_id": 34754387,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) ECG monitoring should be done to look for QTc prolongation and drug is avoided or should be stopped if QTc >500ms. Explanation: Hydroxychloroquine (HCQ) is commonly used in the treatment of various conditions, including COVID-19, lupus, and rheumatoid arthritis. However, it has a well-documented risk of QTc prolongation, which can lead to torsades de pointes, a potentially fatal arrhythmia. Monitoring the QTc interval on ECG is crucial during treatment with HCQ, especially in patients with risk factors for arrhythmias. Option C is correct because the QTc interval should be closely monitored, and if it exceeds 500 ms, HCQ should be avoided or discontinued. This threshold is widely recommended in clinical guidelines to prevent dangerous arrhythmias. The QTc interval is a corrected value for heart rate, and a prolonged QT interval increases the risk of arrhythmic events. Explanation of Incorrect Options: Option A: SpO2 of the patient should be monitored since the drug causes eosinophilic lung disease – Incorrect. While HCQ can cause various side effects, eosinophilic lung disease is not a common or major issue associated with this drug. SpO2 monitoring is important for overall management of patients with respiratory conditions, but it is not a specific concern for HCQ. There is no direct evidence supporting the need for SpO2 monitoring to prevent eosinophilic lung disease induced by HCQ. Option B: BP monitoring should be done and drug should be stopped if BP 320ms – Incorrect. A QTc of 320 ms is considered normal and does not pose a risk for arrhythmias. The threshold for concern is typically QTc > 500 ms, at which point HCQ should be stopped. A QTc value of 320 ms is well within the normal range and does not warrant discontinuation of the drug.",
      "correct_choice_id": 207549,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95805,
      "choices": [
        {
          "id": 207551,
          "text": "Increased total lung capacity (TLC)"
        },
        {
          "id": 207552,
          "text": "Increased residual volume (RV)"
        },
        {
          "id": 207553,
          "text": "Decreased forced vital capacity (FVC)"
        },
        {
          "id": 207554,
          "text": "Decreased forced expiratory volume at 1 second (FEV1)"
        }
      ],
      "text": "You are examining a patient who has presented with dyspnea for 2 years. He is a chronic smoker.He gives h/o wheezing for past 1 week.On examination he has barrel shaped chest.Respiratory rate is 18m/minute.Chest- bilateral ronchi are present.Chest x ray shows hyperinflated lung fields.You order a pulmonary function tests.What part of pulmonary function testing would wheezing correspond to?",
      "unique_key": "Q7792457",
      "question_audio": null,
      "question_video": null,
      "map_id": 34449231,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Decreased forced expiratory volume at 1 second (FEV1). This patient, a chronic smoker, presents with a long history of dyspnea, wheezing, and a barrel-shaped chest, which are typical findings in chronic obstructive pulmonary disease (COPD). COPD is characterized by airflow limitation, and one of the key diagnostic features is a decreased FEV1. FEV1 measures the volume of air a person can exhale in the first second of forced expiration. In obstructive diseases like COPD, the ability to expel air is reduced due to narrowed airways, leading to a decreased FEV1. Wheezing is also a sign of airway obstruction, which further supports the connection between decreased FEV1 and wheezing. Incorrect Options: A. Increased total lung capacity (TLC): TLC is typically increased in obstructive lung diseases like COPD due to air trapping. However, TLC itself is not directly related to wheezing. The primary issue in COPD is airflow limitation, which affects FEV1, rather than the overall lung volume. B. Increased residual volume (RV): Residual volume is the amount of air left in the lungs after a maximal exhalation. In COPD, increased RV is a common finding due to air trapping, but RV is not the most directly related measure to wheezing. Wheezing is more indicative of the difficulty in exhaling air quickly, which affects FEV1. C. Decreased forced vital capacity (FVC): FVC is the total amount of air exhaled during a forced breath. While a decreased FVC can occur in obstructive lung diseases, it is less specific for wheezing compared to a decreased FEV1. FEV1 is more directly affected by the airway obstruction that causes wheezing.",
      "correct_choice_id": 207554,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19790291705049884/19790291705049884.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19790291705049884/19790291705049884.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95806,
      "choices": [
        {
          "id": 207555,
          "text": "Pre renal ARF"
        },
        {
          "id": 207556,
          "text": "Trimethoprim (in cotrimoxazole)decreases the tubular secretion of creatinine"
        },
        {
          "id": 207557,
          "text": "Pneumocystis causes renal failure"
        },
        {
          "id": 207558,
          "text": "Steroid effect"
        }
      ],
      "text": "In continuation of previous clinical case patient was started on cotrimoxazole,oxygen support and 5 days course of steroids.He improved clinically.He was discharged in a stable condition on ART and cotrimoxazole.He comes for follow up after 2 weeks.Lab reports shows-serum Creatinine 1.8 mg/dL (elevated),Blood urea nitrogen (BUN):16 mg/dl, Sodium: 136 mEq/L (normal 135–145 mEq/L).What is the cause of elevated serum creatinine",
      "unique_key": "Q8287339",
      "question_audio": null,
      "question_video": null,
      "map_id": 34604852,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Trimethoprim (in cotrimoxazole) decreases the tubular secretion of creatinine. Trimethoprim, one of the components of cotrimoxazole, can cause a transient increase in serum creatinine due to its inhibition of the tubular secretion of creatinine in the kidneys. This does not represent true renal failure but rather a benign, non-oliguric increase in serum creatinine. This is a known side effect of trimethoprim and can occur even in patients with normal kidney function. The serum creatinine increase in this patient is most likely due to this effect of trimethoprim, especially in the context of normal BUN and sodium levels, which do not indicate significant renal dysfunction. Incorrect Options: A. Pre renal ARF: Pre-renal acute renal failure (ARF) is typically caused by decreased renal perfusion (e.g., dehydration, heart failure, or blood loss), leading to elevated BUN and creatinine. In this case, the normal BUN (16 mg/dL) and the normal sodium (136 mEq/L) make pre-renal ARF unlikely. The patient has no signs of dehydration or reduced renal perfusion, so this option is less likely. C. Pneumocystis causes renal failure: Pneumocystis jiroveci pneumonia (PCP) itself does not typically cause renal failure. Renal impairment in these patients is more likely related to medications (such as cotrimoxazole) or other opportunistic infections. There is no evidence in this patient's clinical course to suggest that PCP itself caused renal failure. D. Steroid effect: Steroids can have side effects such as fluid retention, hyperglycemia, and electrolyte imbalances, but they do not directly cause elevations in serum creatinine. The elevated creatinine here is more likely due to trimethoprim and not from the steroid therapy.",
      "correct_choice_id": 207556,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69075581705050019/69075581705050019.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69075581705050019/69075581705050019.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95807,
      "choices": [
        {
          "id": 207559,
          "text": "Lymph node biopsy on bronchoscopy"
        },
        {
          "id": 207560,
          "text": "BALwith increased CD4 cells"
        },
        {
          "id": 207561,
          "text": "Biopsy of erythema nodosum on shins"
        },
        {
          "id": 207562,
          "text": "ACE level"
        }
      ],
      "text": "A 40 year old female presented with history of fever, ankle joint pains, dry cough with dyspnea on exertion for last 2 months. Initially symptoms of fever and joint pain improved on taking paracetamol but now there is no relief. She also have noticed nodular lesions on legs. On examination- pallor present, respiratory/CVS/CNS-normal. No peripheral lymphadenopathy. Chest x ray shows bilateral hilar lymphadenopathy. Which of the following is the most accurate test?",
      "unique_key": "Q2044758",
      "question_audio": null,
      "question_video": null,
      "map_id": 34696975,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Lymph node biopsy on bronchoscopy. In this patient, the clinical presentation is highly suggestive of sarcoidosis, a granulomatous disease that can involve multiple organ systems, including the lungs, skin, and joints. Bilateral hilar lymphadenopathy is a classic radiographic finding in sarcoidosis. Additionally, the presence of fever, joint pain, and erythema nodosum (the nodular lesions on the legs) further support the diagnosis of sarcoidosis, as these are common extra-pulmonary manifestations. To confirm the diagnosis, a lymph node biopsy is typically performed. This biopsy can be obtained through bronchoscopy with transbronchial biopsy or via other methods, such as mediastinoscopy. The biopsy typically shows non-caseating granulomas, which are pathognomonic for sarcoidosis. Incorrect Options: B. BAL with increased CD4 cells: Bronchoalveolar lavage (BAL) with an increased CD4/CD8 ratio is often seen in sarcoidosis and can support the diagnosis, but it is not the most accurate test for definitive diagnosis. While BAL findings can be helpful, the lymph node biopsy provides a direct histological diagnosis by showing non-caseating granulomas, which is more conclusive. C. Biopsy of erythema nodosum on shins: Although erythema nodosum is a characteristic feature of sarcoidosis, a biopsy of the skin lesions is not necessary for diagnosis. The skin findings are typically considered part of the overall clinical picture, and the diagnosis can be made based on clinical, radiographic, and histopathologic findings from other sites, such as the lungs or lymph nodes. A skin biopsy would not be the most accurate test. D. ACE level: Angiotensin-converting enzyme (ACE) levels are often elevated in patients with sarcoidosis, but this is a non-specific marker. Elevated ACE levels can be seen in other conditions as well, so while they can be supportive of the diagnosis, they are not definitive. The lymph node biopsy provides the most accurate and definitive diagnostic information.",
      "correct_choice_id": 207559,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47788381705050133/47788381705050133.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47788381705050133/47788381705050133.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}